glp 1 glucagon dual receptor agonist Schematic illustration of monoagonists, agonists and triple Major physiological roles of GLP-1

Weight loss without exercise is possible through diet alone, but combining dietary changes with regular physical activity improves outcomes across every metric, from fat loss to muscle preservation to metabolic health

Still, insurance coverage and cost considerations mean both drugs remain relevant, and patient-centred conversations about therapy choice are critical. GLP-1s beyond weight loss as multi-system therapies Liver disease and metabolic steatohepatitis Non-alcoholic fatty liver disease (NAFLD) and the more severe metabolic dysfunction-associated steatohepatitis (MASH) have few effective pharmacologic treatments

Boehringer Ingelheim maintains niche loyalty for dulaglutide via its auto-injector design, though share erosion is visible

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

Theyre meant to be taken long-term alongside lifestyle changes, and under a healthcare providers supervision

Secreted GLP-1 then impedes gastrointestinal motility at the level of myenteric neurons by inhibiting downstream signaling of nitric oxide and cyclic adenosine monophosphate (cAMP) dependent pathways that inhibit vagal activity [10]